Related references
Note: Only part of the references are listed.In vitro effects of European and Latin-American medicinal plants in CYP3A4 gene expression, glutathione levels, and P-glycoprotein activity
Andre Luis Dias Araujo Mazzari et al.
FRONTIERS IN PHARMACOLOGY (2022)
Developmental Changes in Pharmacokinetics and Pharmacodynamics
John van den Anker et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Phenotypic and genotypic analyses of diversity and breeding progress in European triticale (X Triticosecale Wittmack)
Dominik Losert et al.
PLANT BREEDING (2017)
Curcumin: A Review of Its Effects on Human Health
Susan J. Hewlings et al.
FOODS (2017)
Co-administration of Fluvastatin and CYP3A4 and CYP2C8 Inhibitors May Increase the Exposure to Fluvastatin in Carriers of CYP2C9 Genetic Variants
Yuji Mukai et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2017)
A Pharmacokinetic Study Examining Acetazolamide as a Novel Adherence Marker for Clinical Trials
Aidan J. Hampson et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Assessment of Potential Herb-Drug Interactions among Nigerian Adults with Type-2 Diabetes
Udoamaka Ezuruike et al.
FRONTIERS IN PHARMACOLOGY (2016)
P-glycoprotein and its role in drug-drug interactions
Andrew Finch et al.
Australian Prescriber (2016)
Everything we always wanted to know about furosemide but were afraid to ask
Xiaohua Huang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
Garlic and Onions: Their Cancer Prevention Properties
Holly L. Nicastro et al.
CANCER PREVENTION RESEARCH (2015)
Brinzolamide/Brimonidine: A Review of Its Use in Patients with Open-Angle Glaucoma or Ocular Hypertension
Sarah L. Greig et al.
DRUGS & AGING (2015)
Practical pharmacokinetics: what do you really need to know?
E. S. Starkey et al.
ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION (2015)
Pharmacokinetics
Jianghong Fan et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Converging Indications of Aldosterone Antagonists (Spironolactone and Eplerenone): A Narrative Review of Safety Profiles
Mohammed I. Danjuma et al.
CURRENT HYPERTENSION REPORTS (2014)
Antihypertensive Drugs Metabolism: An Update to Pharmacokinetic Profiles and Computational Approaches
Aikaterini Zisaki et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Diuretics: A Review and Update
George C. Roush et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2014)
Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies
Yow-Wen Hsieh et al.
SCIENTIFIC REPORTS (2014)
Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions
Andre L. D. A. Mazzari et al.
FRONTIERS IN PHARMACOLOGY (2014)
In Vitro Drug Metabolism by Human Carboxylesterase 1: Focus on Angiotensin-Converting Enzyme Inhibitors
Ragnar Thomsen et al.
DRUG METABOLISM AND DISPOSITION (2014)
Which thiazide to choose as add-on therapy for hypertension?
Vivencio Barrios et al.
INTEGRATED BLOOD PRESSURE CONTROL (2014)
The P-Glycoprotein Transport System and Cardiovascular Drugs
Jeffrey D. Wessler et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?
S. Casey Laizure et al.
PHARMACOTHERAPY (2013)
Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: A literature review comparing amlodipine and nifedipine GITS
Corey B. Toal et al.
BLOOD PRESSURE (2012)
Effects of atorvastatin metabolites on induction of drug-metabolizing enzymes and membrane transporters through human pregnane X receptor
E. Hoffart et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Loop diuretics in heart failure
G. Michael Felker
HEART FAILURE REVIEWS (2012)
Pharmacokinetic Herb-Drug Interactions (Part 1): Origins, Mechanisms, and the Impact of Botanical Dietary Supplements
Bill J. Gurley
PLANTA MEDICA (2012)
Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network
Christopher G. Rowan et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Pregnane X receptor mediates the induction of P-glycoprotein by spironolactone in HepG2 cells
Juan Pablo Rigalli et al.
TOXICOLOGY (2011)
Statin regulation of CYP3A4 and CYP3A5 expression
Maria Alice Vieira Willrich et al.
PHARMACOGENOMICS (2009)
Herbal medicine research and global health: an ethical analysis
Jon C. Tilburt et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin
Pertti J. Neuvonen et al.
CLINICAL PHARMACOKINETICS (2008)
Inhibition of cell growth and glutathione depletion by calcium channel blockers
Moeed Akbar et al.
TOXICOLOGY (2008)
Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics
L. Becquemont et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance
Pertti J. Neuvonen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Limited P-glycoprotein mediated efflux for anti-epileptic drugs
Andrew Crowe et al.
JOURNAL OF DRUG TARGETING (2006)
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
M Schachter
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2005)
CYP2C9 polymorphisms and the interindividual variability in pharmacokinetics and pharmacodynamics of the loop diuretic drug torsemide
SV Vormfelde et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Clinical pharmacokinetics of atorvastatin
H Lennernas
CLINICAL PHARMACOKINETICS (2003)
Share Paper
